• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[法舒地尔抑制Rho激酶预防与痉挛性心绞痛相关的心绞痛发作:一例报告]

[Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].

作者信息

Hiroki Junko, Fukumoto Yoshihiro, Shimokawa Hiroaki, Hirooka Yoshitaka, Takeshita Akira

机构信息

Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka.

出版信息

J Cardiol. 2004 Oct;44(4):161-4.

PMID:15532247
Abstract

An 86-year-old woman was admitted with unstable angina pectoris. Plain old balloon angioplasty (POBA) was performed for 90% stenosis at segment 7 of the left coronary artery with concomitant treatment with nitrate, calcium antagonists, and nicorandil. Five days after POBA, she again suffered chest pain at rest with ST depression by electrocardiography, despite increased doses of calcium-antagonist and nicorandil. Coronary arteriography showed no evidence of restenosis (50%) at the POBA site. The involvement of coronary artery spasm was considered and intravenous treatment with a Rho-kinase inhibitor, fasudil, was started, which resulted in disappearance of the anginal attacks. She refused to continue the fasudil treatment on day 5, which resulted in reappearance of anginal attacks. Third coronary angiography showed a 90% restenosis at POBA site and percutaneous coronary intervention was again performed. This case suggests that a Rho-kinase inhibitor is potentially effective to prevent anginal attacks in spastic angina.

摘要

一名86岁女性因不稳定型心绞痛入院。对左冠状动脉第7节段90%狭窄处进行了单纯球囊血管成形术(POBA),同时使用硝酸盐、钙拮抗剂和尼可地尔进行治疗。POBA术后5天,尽管增加了钙拮抗剂和尼可地尔的剂量,但她仍再次出现静息性胸痛,心电图显示ST段压低。冠状动脉造影显示POBA部位无再狭窄(50%)迹象。考虑冠状动脉痉挛的可能性,开始静脉注射Rho激酶抑制剂法舒地尔进行治疗,结果心绞痛发作消失。第5天她拒绝继续使用法舒地尔治疗,随后心绞痛发作再次出现。第三次冠状动脉造影显示POBA部位出现90%再狭窄,再次进行了经皮冠状动脉介入治疗。该病例表明,Rho激酶抑制剂可能对预防痉挛性心绞痛的心绞痛发作有效。

相似文献

1
[Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].[法舒地尔抑制Rho激酶预防与痉挛性心绞痛相关的心绞痛发作:一例报告]
J Cardiol. 2004 Oct;44(4):161-4.
2
Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.冠状动脉内注射法舒地尔抑制 Rho 激酶可预防冠状动脉微血管痉挛患者的心肌缺血。
J Am Coll Cardiol. 2003 Jan 1;41(1):15-9. doi: 10.1016/s0735-1097(02)02632-3.
3
Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery.Rho激酶抑制剂法舒地尔治疗冠状动脉搭桥术后顽固性严重冠状动脉痉挛的有效性
J Cardiovasc Pharmacol. 2004 Sep;44(3):275-7. doi: 10.1097/01.fjc.0000134775.76636.3f.
4
Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.Rho激酶抑制剂法舒地尔对变异性心绞痛患者冠状动脉痉挛的抑制作用
Circulation. 2002 Apr 2;105(13):1545-7. doi: 10.1161/hc1002.105938.
5
Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.Rho激酶抑制剂法舒地尔对重度肺动脉高压患者的急性血管舒张作用
Heart. 2005 Mar;91(3):391-2. doi: 10.1136/hrt.2003.029470.
6
Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.在稳定型心绞痛患者的同心冠状动脉狭窄中,后续给予Rho激酶抑制剂法舒地尔的血管舒张作用超过硝酸甘油。
Circ J. 2006 Apr;70(4):402-8. doi: 10.1253/circj.70.402.
7
Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina.Rho激酶抑制剂羟基法舒地尔在犬劳力性心绞痛模型中的抗心绞痛作用
Br J Pharmacol. 2001 Dec;134(8):1724-30. doi: 10.1038/sj.bjp.0704410.
8
Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.Rho激酶抑制剂法舒地尔对稳定型劳力性心绞痛患者的抗心绞痛作用:一项多中心研究。
J Cardiovasc Pharmacol. 2002 Nov;40(5):751-61. doi: 10.1097/00005344-200211000-00013.
9
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.Rho激酶抑制作用可改善冠心病患者的内皮功能。
Circ Res. 2006 Dec 8;99(12):1426-32. doi: 10.1161/01.RES.0000251668.39526.c7. Epub 2006 Nov 9.
10
Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.在使用硝酸甘油后给予Rho激酶抑制剂法舒地尔,可使变异性心绞痛患者的冠状动脉痉挛部位进一步扩张。
Coron Artery Dis. 2008 Mar;19(2):105-10. doi: 10.1097/MCA.0b013e3282f3420c.

引用本文的文献

1
Effectiveness of continuous low-dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest.持续低剂量法舒地尔对心肺复苏后难治性冠状动脉痉挛的疗效
Clin Case Rep. 2017 Jun 8;5(8):1207-1209. doi: 10.1002/ccr3.830. eCollection 2017 Aug.
2
Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.性激素代谢对绝经后激素治疗心血管疾病中血管作用的影响。
Curr Drug Metab. 2010 Oct;11(8):693-714. doi: 10.2174/138920010794233477.
3
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.
Rho 激酶抑制:心血管疾病治疗的新靶点。
Drug Discov Today. 2010 Aug;15(15-16):622-9. doi: 10.1016/j.drudis.2010.06.011. Epub 2010 Jun 25.
4
New approaches to the treatment of pulmonary hypertension: from bench to bedside.肺动脉高压治疗的新方法:从实验室到临床。
Cardiol Rev. 2010 Mar-Apr;18(2):76-84. doi: 10.1097/CRD.0b013e3181cbcbf3.